Interview with Ala Ciobanu, General Manager, Roche Ukraine
As a leader responsible for heading Roche’s operations since its establishment of an LLC in Ukraine in 2009, what do you consider have been the main achievements of the company?…
Address: The Arterium Corporation, 139 Saksaganskogo str., Kyiv, Ukraine, 01032,Ukraine
Tel: (+38 044) 490 75 22
Web: http://www.arterium.ua/en/
The Arterium Corporation operates in the industry which takes care of the most important values – human health and life. Every day nearly two thousand of our employees make their individual contribution to the achievement of this humane goal. The Arterium Corporation strives to ensure that every patient who uses its medicines, every doctor who is determined to overcome disease, and every business partner – feels the care, responsibility and confidence they put into the high quality and effectiveness of their products. That is why the Arterium Corporation has a corporate philosophy and attitude of cooperation towards patients, doctors and business partners which is firmly based on the concept “Closer to people”.
Anesthesioloy, Cardiology, Dermatology, Endocrinology, Gastroenterology, Gynaeocology, Haematology, Infectology, Narcology, Neurology, Neurosurgery, Oncology, Otolarygology, Surgery, Pediatrics, Phthisiatry, Therapy, Traumatology, Veterinary Medicine
As a leader responsible for heading Roche’s operations since its establishment of an LLC in Ukraine in 2009, what do you consider have been the main achievements of the company?…
Nobel Pharma has quite a history in the CIS region as this region is becoming increasingly important for the company. What is the company’s story in Ukraine? Nobel Pharma Ukraine…
Let us start with the history of InterChem which is quite unique and started as a chemical company with a very small group from the National Academy of Sciences. Please…
It has been almost a decade since Mili Healthcare began its operations in Ukraine today becoming one of the top 20 leading foreign companies in the local industry. What were…
If you could provide our readers with your philosophy when you founded Sayenko Kharenko in 2004. What were the market needs that were perhaps missing that you identified and wanted…
It has been one year since you were appointed as the head of UCB’s operations in Ukraine. What was the mission of your assignment when you took this position and…
Considering you only took over as CEO from your father in 2009, what was the mandate that was given to you as new CEO of the company – including your…
Orion’s global strategy focuses on the CIS and Eastern European markets that still exhibit large growth potential and are expanding, despite a reverse trend for the rest of the industry.…
What were the factors that led to Sanofi’s decision to establish an LLC in 2009 in Ukraine, and how has it changed your operations? Most of the major foreign companies…
Ipsen has showed some very positive results worldwide in 2010 and so far this year, specifically in non-Western European markets that grew by 12% in 2010. How have the Ukrainian…
Since the establishment of Astellas’ predecessor Brocade in Russia in 1992, what has been Astellas’ evolution in Ukraine? Astellas has been present in Ukraine for 16 years, first as Yamanouchi…
See our Cookie Privacy Policy Here
